Michael J. Murphy
Editor

2012

Developments in genomic and proteomic technologies are shedding light on the molecular pathobiology of melanoma, and uncovering diagnostic and prognostic biomarkers and therapeutic targets for this deadly disease. In this book, experts review recent major advances in melanoma biomarker research.